Showing results (841-850 of 889) with videos related to
Sort By:
Pageof 89
Drugs in R&D|November 14, 2016
Efficacy of Immunobiologic and Small Molecule Inhibitor Drugs for Psoriasis: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsAndré Vicente Esteves de Carvalho, Rodrigo Pereira Duquia, Bernardo Lessa Horta, et al.Drugs in R&D|January 8, 2017
Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System DataRemington L Nevin, Jeannie-Marie LeoutsakosDrugs in R&D|January 8, 2017
Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic DiseaseRebecca J Gryka, Leo F Buckley, Sarah M AndersonDrugs in R&D|December 23, 2016
Population Pharmacokinetics and Pharmacodynamics Modelling of Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress SyndromeShuying Yang, Teodora Pene DumitrescuDrugs in R&D|March 19, 2014
Managing the child with severe primary insulin-like growth factor-1 deficiency (IGFD): IGFD diagnosis and managementJay Cohen, Sandra Blethen, Joyce Kuntze, et al.Drugs in R&D|April 16, 2014
Valproate-induced liver injury: modulation by the omega-3 fatty acid DHA proposes a novel anticonvulsant regimenMarwa A Abdel-Dayem, Ahmed A Elmarakby, Azza A Abdel-Aziz, et al.Drugs in R&D|May 7, 2008
Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice settingAndrew J Dowson, Shaun G Kilminster, Rebecca SaltDrugs in R&D|May 7, 2008
Agomelatine: AGO 178, AGO178, S 20098Drugs in R&D|May 7, 2008
AlfimepraseDrugs in R&D|February 27, 2008
Difficulties in the production of identical drug products from a pharmaceutical technology viewpointArmando A Genazzani, Franco PattarinoPageof 89